An Algorithm Approach to Determining Smoking Cessation Treatment for Persons Living With HIV/AIDS: Results of a Pilot Trial

Journal of Acquired Immune Deficiency Syndromes

Volumn 69, Issue 3, 2015, Pages 291-298

  Cropsey, Karen L ^a   Jardin, Bianca F ^b   Burkholder, Greer A ^c   Clark, C Brendan ^a   Raper, James L ^c   Saag, Michael S ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Roper St Francis Hospital   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

AIDS; algorithm; HIV; proactive; smoking cessation

Indexed keywords

AMFEBUTAMONE; NICOTINE LOZENGE; NICOTINE PATCH; VARENICLINE; BENZAZEPINE DERIVATIVE; DOPAMINE UPTAKE INHIBITOR; NICOTINE GUM; NICOTINIC AGENT; QUINOXALINE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALGORITHM; ARTICLE; DISEASE REGISTRY; ELECTRONIC MEDICAL RECORD; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOTIVATION; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; SMOKING CESSATION; TREATMENT DURATION; ADVERSE EFFECTS; COMPLICATION; CONTROLLED STUDY; DRUG THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SMOKING;

ADULT; ALGORITHMS; BENZAZEPINES; BUPROPION; DOPAMINE UPTAKE INHIBITORS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NICOTINIC AGONISTS; PILOT PROJECTS; QUINOXALINES; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; VARENICLINE;

EID: 84933038515     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000579     Document Type: Article

References (35)

1. Helleberg M, Afzal S, Kronborg G, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis. 2013;56:727-734.
2. Rahmanian S, Wewers ME, Koletar S, et al. Cigarette smoking in the HIV-infected population. Proc Am Thorac Soc. 2011;8:313-319.
3. Mangili A, Polak JF, Skinner SC, et al. HIV infection and progression of carotid and coronary atherosclerosis: the CARE study. J Acquir Immune Defic Syndr. 2011;58:148-153.
4. De P, Farley A, Lindson N, et al. Systematic review and meta-analysis: influence of smoking cessation on incidence of pneumonia in HIV. BMC Med. 2013;11:15.
5. Niaura R, Shadel WG, Morrow K, et al. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis. 2000;31:808-812.
6. Benard A, Bonnet F, Tessier JF, et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care and STDS. 2007;21:458-468.
7. Lifson AR, Neuhaus J, Arribas JR, et al. Smoking-related health risks among persons with HIV in the strategies for management of antiretroviral therapy clinical trial. Am J Public Health. 2010;100:1896-1903.
8. Fiore C, Jaen CR. Treating Tobacco Use and Depencence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Public Health Service; 2008.
9. Fu SS, van Ryn M, Sherman SE, et al. Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial. JAMA Intern Med. 2014;174:671-677.
10. Jardin BF, Cropsey KL, Wahlquist AE, et al. Evaluating the effect of access to free medication to quit smoking: a clinical trial testing the role of motivation. Nicotine Tob Res. 2014;16:992-999.
11. Carpenter MJ, Hughes JR, Gray KM, et al. Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial. Arch Intern Med. 2011;171:1901-1907.
12. Vidrine DJ, Arduino RC, Lazev AB, et al. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS. 2006;20:253-260.
13. Vidrine DJ, Marks RM, Arduino RC, et al. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res. 2012;14:106-110.
14. Cropsey KL, Hendricks PS, Jardin B, et al. A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV. Addict Behav. 2013;38:2541-2546.
15. Shuter J, Bernstein SL, Moadel AB. Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS. Am J Health Behav. 2012;36:75-85.
16. Bader P, McDonald P, Selby P. An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts. Tob Control. 2009;18:34-42.
17. Hughes J. An algorithm for choosing among smoking cessation treatments. J Subst Abuse Treat. 2008;34:426-432.
18. Hughes JR. An updated algorithm for choosing among smoking cessation treatments. J Subst Abuse Treat. 2013;45:215-221.
19. Jones SJ, Gardner CL, Cleveland KK. Development of a smoking cessation algorithm for primary care providers. J Nurse Pract. 2014;10:120-127.
20. Barst RJ, Gibbs JS, Ghofrani HA, et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(1 suppl):S78-S84.
21. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32:193-203.
22. Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerstrom test for cigarette dependence. Nicotine Tob Res. 2012;14:75-78.
23. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43:289-294.
24. Hendricks PS, Wood SB, Baker MR, et al. The Smoking Abstinence Questionnaire: measurement of smokers' abstinence-related expectancies. Addiction. 2011;106:716-728.
25. Garrison GD, Dugan SE. Varenicline: a first-line treatment option for smoking cessation. Clin Ther. 2009;31:463-491.
26. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11:CD000146.
27. Carpenter MJ, Jardin BF, Burris JL, et al. Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature. Drugs. 2013;73:407-426.
28. USDHS. Cigarette smoking-United States, 1965-2005. MMWR. 2011; 60:109-113.
29. Moscou-Jackson G, Commodore-Mensah Y, Farley J, et al. Smoking-cessation interventions in people living with HIV infection: a systematic review. J Assoc Nurses AIDS Care. 2014;25:32-45.
30. Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58:721-728.
31. Dervaux A, Laqueille X. Antidepressant treatment and smoking cessation in bipolar disorder. JAMA. 2009;301:2093; author reply.
32. Vangeli E, Stapleton J, Smit ES, et al. Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction. 2011;106:2110-2121.
33. Carpenter MJ, Alberg AJ, Gray KM, et al. Motivating the unmotivated for health behavior change: a randomized trial of cessation induction for smokers. Clin Trials. 2010;7:157-166.
34. Cioe PA. Smoking cessation interventions in HIV-infected adults in North America: a literature review. J Addict Behav Ther Rehabil. 2013;2:1000112.
35. Zhu SH, Lee M, Zhuang YL, et al. Interventions to increase smoking cessation at the population level: how much progress has been made in the last two decades? Tob Control. 2012;21:110-118.